Cargando…
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
The treatment of melanoma has been revolutionized by new therapies targeting MAPK signaling or the immune system. Unfortunately these therapies are hindered by either primary resistance or the development of acquired resistance. Resistance mechanisms involving somatic mutations in genes associated w...
Autores principales: | Gallagher, Stuart J, Tiffen, Jessamy C, Hersey, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695870/ https://www.ncbi.nlm.nih.gov/pubmed/26426052 http://dx.doi.org/10.3390/cancers7040870 |
Ejemplares similares
-
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma
por: Tiffen, Jessamy, et al.
Publicado: (2016) -
Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
por: Punnia-Moorthy, Gaya, et al.
Publicado: (2021) -
Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
por: Gowrishankar, Kavitha, et al.
Publicado: (2015) -
Sex bias of females in survival from cancer and infections. Is X the answer?
por: Emran, Abdullah Al, et al.
Publicado: (2021) -
Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
por: Emran, Abdullah Al, et al.
Publicado: (2020)